This protocol is judged by an institutional critique board, an independent group that evaluations any medical trials involving people. If a research requires a Plan I drug, after the board approves the protocol as ethical, the scientists have to submit an application for an investigational new drug (IND) quantity from the FDA.Some scientists and co